Evidence map›Paper›PMID 38741895›Full record

ArticleJAC-antimicrobial resistance2024

Emergence of an IncX3 plasmid co-harbouring the carbapenemase genes

Hui Zuo, Yo Sugawara, Kohei Kondo, Shizuo Kayama, Sayoko Kawakami, Kohei Uechi, Ami Nakano, Koji Yahara, Motoyuki Sugai

Abstract read
In one paragraph

Article in JAC-antimicrobial resistance, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Global spread of carbapenem-resistantOne health (Amsterdam, Netherlands) · 2026
    Article
  2. Cross-species transmission ofFrontiers in cellular and infection microbiology · 2026
    Review
  3. Plasmid genomic epidemiology ofMicrobial genomics · 2025
    Article
  4. Multispecies emergence of dualAntimicrobial agents and chemotherapy · 2025
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hui ZuoAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Yo SugawaraAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan.ORCID https://orcid.org/0000-0002-9897-3905
Kohei KondoAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Shizuo KayamaAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Sayoko KawakamiAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Kohei UechiDivision of Clinical Laboratory and Blood Transfusion, University of the Ryukyus Hospital, Okinawa, Japan.
Ami NakanoDivision of Clinical Laboratory and Blood Transfusion, University of the Ryukyus Hospital, Okinawa, Japan.
Koji YaharaAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Motoyuki SugaiAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The spread of transmissible plasmids with carbapenemase genes has contributed to a global increase in carbapenemase-producing Enterobacterales over the past two decades, with Objectives: To characterize an Methods: The whole-genome sequence of the isolate was determined using long- and short-read sequencing. Growth assay and co-culture experiments were performed for phenotypic characterization in the presence of different β-lactam antibiotics. Results: WGS analysis showed that Conclusions: The additional carriage of

Identifiers

PMID38741895
PMCPMC11089413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.